These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7788816)

  • 21. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measurement of cellular DNA content in thyroid tumors by the flow cytometer].
    Motomura Y
    Nihon Geka Gakkai Zasshi; 1988 Jul; 89(7):1066-74. PubMed ID: 3221827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear DNA measurements in follicular thyroid adenomas.
    Bäckdahl M; Wallin G; Askensten U; Auer G; Grimelius L; Löwhagen T
    Eur J Surg Oncol; 1989 Apr; 15(2):125-9. PubMed ID: 2703057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computerized nuclear morphometry and quantitation of angiogenesis in thyroid neoplasms.
    Kavantzas N; Tseleni-Balafouta S; Davaris P
    J Exp Clin Cancer Res; 2002 Jun; 21(2):247-54. PubMed ID: 12148586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of morphonuclear features in normal, benign and neoplastic thyroid tissue by digital cell image analysis.
    Salmon I; Kiss R; Franc B; Gasperin P; Heimann R; Pasteels JL; Verhest A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):47-54. PubMed ID: 1558615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
    Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
    Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical pathology of the thyroid gland in Iraq. A study of 200 cases.
    Al-Saleem T; Al-Ashbal A
    Int Surg; 1973 Sep; 58(9):623-7. PubMed ID: 4800296
    [No Abstract]   [Full Text] [Related]  

  • 33. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
    Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
    J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Flow cytometry of thyroid tumors. Study of fresh tissue in 50 patients].
    Suissa J; Hoang C; Soubrane C; Chigot JP; Khayat D; Leenhardt L; Aurengo A; Turpin G; Le Charpentier Y
    Presse Med; 1994 Feb; 23(4):159-63. PubMed ID: 8177857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
    Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
    Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical pathology.
    Meissner WA
    Major Probl Clin Surg; 1980; 15():39-69. PubMed ID: 6893731
    [No Abstract]   [Full Text] [Related]  

  • 38. The tall cell variant of papillary carcinoma of the thyroid gland. Comparison with the common form of papillary carcinoma by DNA and morphometric analysis.
    Flint A; Davenport RD; Lloyd RV
    Arch Pathol Lab Med; 1991 Feb; 115(2):169-71. PubMed ID: 1992985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preoperative prediction of the character of strumas].
    Teuscher J; Ehrengruber H; Ballmer F
    Chirurg; 1986 Mar; 57(3):155-8. PubMed ID: 3709290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours.
    Yeh JJ; Lunetta KL; van Orsouw NJ; Moore FD; Mutter GL; Vijg J; Dahia PL; Eng C
    Oncogene; 2000 Apr; 19(16):2060-6. PubMed ID: 10803467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.